返回 
加入收藏
不同剂量美罗培南治疗脓毒症休克的临床效果比较
x
请在关注微信后，向客服人员索取文件
| 篇名： | 不同剂量美罗培南治疗脓毒症休克的临床效果比较 |
| TITLE： | Comparison of clinical effects of different doses of meropenem in the treatment of septic shock |
| 摘要： | 目的 比较不同剂量美罗培南治疗脓毒症休克的临床效果。方法将106例脓毒症休克患者按随机数字表法分为标准剂量组和高剂量组，每组53例。标准剂量组患者予以标准剂量美罗培南（首次静脉滴注美罗培南1g，持续30min以上，然后每8h静脉滴注美罗培南1g，每次3h以上）；高剂量组患者予以高剂量美罗培南（首次静脉滴注美罗培南2g，持续30min以上，然后每8h静脉滴注美罗培南2g，每次3h以上）；其余治疗措施根据患者具体情况而定。主要观察指标为两组患者治疗3、5、7d时的序贯器官衰竭估计（SOFA）评分和简化的急性生理评分Ⅱ（SAPSⅡ）的增量。次要观察指标为两组患者的院内死亡率，90d全因病死率，7d微生物治愈率，7d临床治愈率，治疗3、5、7d时的血清降钙素原（PCT）和C反应蛋白（CRP）水平，重症监护室住院天数，呼吸机治疗天数，去甲肾上腺素最高剂量。同时观察两组患者的不良反应发生情况。结果高剂量组患者治疗7d时的SOFA评分增量、SAPSⅡ增量，治疗5、7d时的PCT、CRP水平以及90d全因病死率均显著低于标准剂量组（P＜0.05）。两组间其他指标比较，差异均无统计学意义（P＞0.05）。结论高剂量美罗培南治疗脓毒症休克相比标准剂量美罗培南具有更好的临床效果，且安全性较好。 |
| ABSTRACT： | OBJECTIVE To compare the clinical effects of different doses of meropenem in the treatment of septic shock. METHODS One hundred and six patients with septic shock were randomly divided into standard-dose group and high-dose group， with 53 cases in each group. Patients in the standard-dose group were given standard dose of meropenem （initial intravenous injection of 1 g meropenem more than 30 minutes， followed by 1 g meropenem intravenously every 8 hours， each time for more than 3 hours）； patients in the high-dose group were given high dose of meropenem （initial intravenous injection of 2 g meropenem more than 30 minutes， followed by 2 g meropenem intravenously every 8 hours， each time for more than 3 hours）； other treatment measures were determined based on the specific conditions of the patients. The main observation indicators were the increments of sequential organ failure assessment （SOFA） scores and simplified acute physiology score Ⅱ （SAPS Ⅱ） after 3， 5 and 7 days of treatment in both groups. Secondary observation indicators included in-hospital mortality， 90-day all-cause mortality， 7-day microbial cure rate， 7-day clinical cure rate， serum procalcitonin （PCT） and C-reactive protein （CRP） levels after 3， 5 and 7 days of treatment， hospitalization days in the intensive care unit， ventilator treatment days， the highest dose of norepinephrine. The occurrence of adverse drug reaction in the two groups was observed. RESULTS The increments of SOFA scores and SAPS Ⅱ after 7 days of treatment， the levels of PCT and CRP after 5 and 7 days of treatment as well as the 90-day all-cause mortality in the high- dose group were significantly lower than the standard-dose group （P＜0.05）. There were no statistically significant differences in other indicators between the two groups （P＞0.05）. CONCLUSIONS High-dose meropenem treatment for septic shock has better clinical effects and is safer than standard-dose meropenem. |
| 期刊： | 2024年第35卷第13期 |
| 作者： | 平泽；张建军；王金荣；柴成国；李宁 |
| AUTHORS： | PING Ze，ZHANG Jianjun，WANG Jinrong，CHAI Chengguo，LI Ning |
| 关键字： | 脓毒症休克；美罗培南；剂量；临床效果 |
| KEYWORDS： | septic shock； meropenem； dose； clinical effect |
| 阅读数： | 4 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
